Should you buy LIC, Divi's Labs, Bandhan Bank, Tata Power, other stocks today? Here is what brokerages recommend

As Dalal Street enters the February 13 session, brokerages have several stocks on their radar. Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Tata Power, LIC, Divi's Laboratories and Bandhan Bank:

Divi's Labs share target price:

Goldman Sachs has maintained a 'neutral' rating on the Divi's Laboratories stock with a target of Rs 3,670.

Jefferies has maintained a 'hold' call on Divi's Labs shares with a target of Rs 3,610.

Aurobindo Pharma share target price:

Macquarie has maintained an 'outperform' rating on the Aurobindo Pharma stock with a target of Rs 1,300

UBL share target price:

JP Morgan has maintained an 'overweight' rating on the UBL stock with a target of Rs 1,950.

Citi has maintained a 'sell' call on UBL shares with a target of Rs 1,600

LIC share target price:

JP Morgan has an 'overweight' rating on Life Insurance Corporation of India (LIC) shares with a target of Rs 1,340

PB Fintech share target price:

Jefferies has a 'buy' call on the PB Fintech stock with a target of Rs 1,150

Morgan Stanley has an 'equal-weight' rating on PB Fintech shares with a target of Rs 1,010

Bandhan Bank share target price:

CLSA has maintained an 'outperform' rating on the Bandhan Bank stock with a target of Rs 250, while JP Morgan has maintained an 'overweight' rating on the stock with target of Rs 270.

Three brokerages, Goldman Sachs, Jefferies and Nomura have a 'buy' call on Bandhan Bank with a target of Rs 274, Rs 290 and Rs 275, respectively.

Macquarie has maintained a 'neutral' rating on Bandhan Bank with a target of Rs 225.

Hero MotoCorp share target price:

Jefferies has maintained a 'buy' call on the Hero MotoCorp stock with a target of Rs 5,650, while Goldman Sachs has maintained a 'sell' call on the stock with a target of Rs 3,730.

CLSA has maintained an 'outperform' rating on Hero MotoCorp shares with a target of Rs 5,264, while JP Morgan has maintained an 'overweight' rating on the stock with a target of Rs 5,180 and the Morgan Stanley brokerage has maintained an 'underweight' rating with a target of Rs 3,638.

Alkem Labs share target price:

Both JP Morgan and Nomura have a 'neutral' rating on the Alkem Laboratories stock with a target of Rs 5,640 and Rs 5,605, respectively.

Jefferies has maintained an 'underperform' rating on Alkem Laboratories shares with a target of Rs 4,470.

Zydus Lifesciences share target price:

Jefferies has maintained a hold call on the Zydus Lifesciences stock with a target of Rs 750

Macquarie has maintained an 'underperform' rating on Zydus Lifesciences shares with a target of Rs 550.

Tata Power share target price:

CLSA has maintained a 'sell' call on the Tata Power stock with a target of Rs 249

Morgan Stanley has maintained an 'underweight' rating on Tata Power shares with a target of Rs 213.